Serum total homocysteine and lipoprotein (a) levels in acute myocardial infarction and their response to treatment with vitamins

Journal of the College of Physicians and Surgeons Pakistan

Volumn 21, Issue 5, 2011, Pages 266-270

  Mujibul Haq, A M ^a   Giasuddin, A S M ^b   Huque, Md Mahbubul ^a  

^a DHAKA MEDICAL COLLEGE   (Bangladesh)

^b UNIVERSITY OF DHAKA   (Bangladesh)

Author keywords

Acute myocardial infarction; Folic acid; Homocysteine; Lipoprotein (a); Vitamin B

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; LIPOPROTEIN A; PYRIDOXINE;

ACUTE HEART INFARCTION; AMINO ACID BLOOD LEVEL; ARTICLE; BANGLADESH; CARDIAC PATIENT; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; INTERVENTION STUDY; LIPOPROTEIN BLOOD LEVEL; MALE; NEPHELOMETRY; RISK FACTOR; SMOKING; TREATMENT DURATION; VITAMIN SUPPLEMENTATION;

BIOLOGICAL MARKERS; CORONARY ARTERY DISEASE; FEMALE; HOMOCYSTEINE; HUMANS; LIPOPROTEIN(A); MYOCARDIAL INFARCTION; VITAMIN B COMPLEX;

EID: 79958755376     PISSN: 1022386X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Antman EM, Selwyn AP, Braunwald E, Lascalzo J. Ischemic heart disease. In: Fauci AS, Braunwald E, Kasper DL, Hauser SL, Longo DL, Jameson JL, et al. editors. Harrison's principles of internal medicine. 17th ed. New York: McGraw-Hill; 2008. p. 1514-26.
2. Libby P. The pathogenesis, prevention and treatment of atherosclerosis. In: Fauci AS, Braunwald E, Kasper DL, Hauser SL, Longo DL, Jameson JL, et al, editors. Harrison's principles of internal medicine. 17th ed. New York: McGraw-Hill; 2008. p. 1501-08.
3. Barghash NA, Elema SM, Hamdi EA, Barghash AA, El-dine R. Role of plasma homocysteine and lipoprotein (a) in coronary artery disease. Br J Biomed Sci 2004; 61:78-83.
4. Edirisinghe SP. Homocysteine-induced thrombosis. Br J Biomed Sci 2004; 61:40-7. Comment in: Br J Biomed Sci 2004; 61:166; author reply 166.
5. Salahuddin MI, Ahmed SI. Homocysteine level in patients with established transmural myocardial infarction. J Coll Physicians Surg Pak 2005; 15:520-3. Comment in: J Coll Physicians Surg Pak 2006; 16:311; author reply 311.
6. Page JH, Chiuve SE, Stampher MJ, Selhub J, Manson JE, Rimm EB. Plasma total cysteine and total homocysteine and risk of myocardial infarction in women: a prospective study. Am Heart J 2010; 159:599-604.
7. 6 on clinical outcome after percutaneous coronary intervention: the swiss heart study: a randomized controlled trial. JAMA 2002; 288:973-9.
8. Nurk E, Tell GS, Vollset SE, Nygard O, Refsum H, Ueland PM. Plasma total homocysteine and hospitalizations for cardiovascular disease: the hordaland homocysteine study. Arch Intern Med 2002; 162:1374-81.
9. Refsum H, Nurk E, Smith AD, Ueland PM, Gjesdal CG, Bjelland I, et al. The hordaland homocysteine study: a community-based study of homocysteine, its determinants, and associations with disease. J Nutr 2006; 136:1731S-40S.
10. Shah SM, Karira KA. Salahuddin. Association of lipoprotein (a) with myocardial infarction. J Coll Physicians Surg Pak 2001; 11:374-8.
11. Kim SH, Jeong MH, Lee MG, Ko JS, Park KH, Sim DS, et al. The relationship between the levels of lipoprotein (a) and fibrinogen and clinical outcome in patients with acute myocardial infarction. Chonnam Med J 2010; 46:38-43.
12. Signorello MG, Pascale R, Leoncini G. Effect of homocysteine on arachidonic acid release in human platelets. Eur J Clin Invest 2002; 32:279-84.
13. Landgren F, Israelsson B, Lindgren A, Hultberg B, Andersson A, Brattstrom L. Plasma homocysteine in acute myocardial infarction: homocysteine lowering effect of folic acid. J Intern Med 1995; 237:381-8.
14. Zaher A, Majmder AAS, Mohibullah AKM, Ali M, Reza AS, Dey A, et al. Homocysteine as a risk factor for coronary artery disease in Bangladeshi population. Bangladesh Heart J 2003; 18: 3-8.
15. Camm AJ, Bunce NH. Cardiovascular disease. In: Kumar P, Clark M, editors. Clinical medicine. 6th ed. Edinburgh: WB Saunders; 2005.
16. Timmis AD, Nathan AW, editors. Essentials of cardiology. 2nd ed. Oxford: Blackwell Scientific Publications; 1993.
17. Giasuddin AS, Jhuma KA, Haq AM. Lipoprotein (a) status in Bangladeshi patients with diabetes mellitus. J Med Coll Women Hosp 2008; 6:74-82.
18. Kirkwood BR, Sterne AC. Essential of medical statistics. 2nd ed. Oxford: Blackwell Science; 2008.
19. 12 concentrations and risk for early-onset coronary artery disease. Am J Clin Nutr 1994; 59:940-8.
20. 12 and DNA damage in coronary artery disease. Hum Genet 2003; 112:171-7. Epub 2002 Nov 13.
21. Sun H, Unoki H, Wang X, Liang J, Ichikawa T, Arai Y, et al. Lipoprotein(a) enhances advanced atherosclerosis and vascular calcification in WHHL transgenic rabbits expressing human apolipoprotein(a). J Biol Chem 2002; 277:47486-92. Epub 2002 Aug 23.
22. Jacobson DW. Homocysteine and vitamins in cardiovascular disease. Clin Chem 1998; 44:1833-43.
23. Pryor WA. Vitamin E and heart disease: basic science to clinical intervention trials. Free Radi Biol Med 2000; 28:141-64.
24. Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. Circulation 2004; 110:227-39.
25. Balbishi EA. Management of hyperlipidemia: new LDL-C targets for persons at high-risk for cardiovascular events. Med Sci Monit 2006; 12:RA34-9. Epub 2006 Jan 26.